PADI4 and rheumatoid arthritis: As such, 1/37 (2.7%) RA subjects had sputum anti-PAD4 positivity in the absence of salivary anti-PAD4 positivity, and 1/37 (2.7%) RA subjects had salivary anti-PAD4 antibody in the absence of sputum positivity.